Episodes 61-75 of 435
Explore Impacts Of Glucose-Lowering Medications in Addition to Metformin
Diabetes DiscourseExplore Impacts Of Glucose-Lowering Medications in Addition to Metformin
Key Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
Diabetes DiscourseKey Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
Diabetes DiscourseBreaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
An Assessment of Automated Insulin Delivery Systems for T1D
Diabetes DiscourseAn Assessment of Automated Insulin Delivery Systems for T1D
A Look at Comprehensive Telehealth for PPDM
Diabetes DiscourseA Look at Comprehensive Telehealth for PPDM
SNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
Diabetes DiscourseSNAP, Food Insecurity, & Healthcare Spending: What Do We Need to Know?
- advertisement
Getting to Know GRADE: A Comparative Study of T2D Treatment
Diabetes DiscourseGetting to Know GRADE: A Comparative Study of T2D Treatment
Exploring Precision Medicine in the Treatment of Diabetes
Diabetes DiscourseExploring Precision Medicine in the Treatment of Diabetes
Can Generic Drugs Be Repurposed for COVID-19 Treatment?
Diabetes DiscourseCan Generic Drugs Be Repurposed for COVID-19 Treatment?
A Fight Against Obesity: Evaluating Clinical Data from the SURMOUNT-1 Trial
Diabetes DiscourseA Fight Against Obesity: Evaluating Clinical Data from the SURMOUNT-1 Trial
Heart Failure Consensus Report: A Review of ADA Recommendations
Diabetes DiscourseHeart Failure Consensus Report: A Review of ADA Recommendations
Exploring AACE Updates on the Management of NAFLD & NASH
Diabetes DiscourseExploring AACE Updates on the Management of NAFLD & NASH
- advertisement
The IRIS Trial: Reviewing Results & Taking a Look at Pioglitazone
Diabetes DiscourseThe IRIS Trial: Reviewing Results & Taking a Look at Pioglitazone
Highlights from the Final Days of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterHighlights from the Final Days of the American Diabetes Association's 82nd Scientific Sessions
Highlights From Day 3 of the American Diabetes Association's 82nd Scientific Sessions
ADA Action CenterHighlights From Day 3 of the American Diabetes Association's 82nd Scientific Sessions























































